Camlin Fine Sciences Ltd.
Fundamentals
- Market cap
- ₹2,619 cr
- P/E
- 94.81×
- ROE
- 0.00%
- Debt / equity
- 0.72
- 52-week range
- 96.30 — 334.70
Company snapshot
Camlin Fine Sciences Ltd.
Chemicals
₹2,597 cr
P/E 94.01×
Latest quarter · Mar 2026
Sales₹425 cr
Net profit₹85 cr
Op. margin+5.0%
EPS₹4.59
Strength & growth
Debt / equity0.72×
Current ratio1.40×
Sales CAGR+13.6%
EPS CAGR−9.3%
The timeline — 4 notes on Camlin Fine Sciences Ltd.
May 2026
- 26 May 26 · 6:56 PM IST Brief Brief · Earnings · Small cap
Camlin Fine Sciences cuts vanillin price guidance as costs surge
Logistics disruptions clipped Q4 revenue by 20%, while management warns of higher raw material costs despite lower US tariffs.
- 26 May 26 · 4:58 PM IST Brief Brief · Earnings · Small cap
Camlin profit on Italian sale masks a still-lossmaking core
Consolidated profit of ₹2,762.72 lakh came from liquidating CPS Europe SpA and adding Vinpai. Standalone losses narrowed but the core business is still in the red.
- 26 May 26 · 4:43 PM IST Brief Brief · Earnings · Small cap
Camlin Fine Sciences cuts standalone losses, but revenue also shrank
Standalone net loss narrowed sharply in FY26, but the improvement came from lower revenue, not growth. Consolidated profit was a one-off from a European liquidation.